超声衍生脂肪分数用于肥胖患者代谢手术后肝脂肪变性正常化的术前预测与监测
前瞻性队列纳入160例拟行代谢手术患者,其中120例经活检证实肝脂肪≥5%者重复评估UDFF。UDFF与组织学脂肪变性分级强相关(ρ=0.78),诊断≥S1的AUC=0.99。基于92例90天随访完成者构建的列线图预测脂肪变性正常化AUC=0.84。
要点
- UDFF与组织学脂肪变性分级强相关(Spearman ρ=0.78,p<0.001),诊断≥S1的AUC=0.99。
- 术后UDFF、体重和甘油三酯呈快速、分阶段下降。
- 基线体重、UDFF和甘油三酯为脂肪变性正常化的独立预测因子(均p<0.05)。
核心结论
- UDFF是量化肝脂肪变性和监测治疗反应的有效无创工具。
- 所构建列线图可用于术前识别脂肪变性正常化延迟风险患者,从而促进个体化手术管理和优化随访策略。
研究设计与样本
- 前瞻性队列研究,纳入160例拟行代谢和减重手术的患者。
- 其中120例经活检证实的代谢功能障碍相关脂肪性肝病(肝脂肪≥5%)患者,在术前及术后30、90和≥180天重复评估UDFF、人体测量学和生化标志物。
- 随访完成率:30天82.5%(99/120),90天76.7%(92/120),≥180天60.0%(72/120)。
- 使用92例完成90天随访患者的数据,通过单变量和多变量logistic回归构建列线图。
- 通过受试者工作特征曲线下面积(AUC)、校准和决策曲线分析评估列线图性能。
诊断标准与关键数值
- UDFF与组织学脂肪变性分级强相关(Spearman ρ=0.78;p<0.001)。
- UDFF诊断≥S1脂肪变性的AUC=0.99。
- 基线体重、UDFF和甘油三酯为脂肪变性正常化的独立预测因子(均p<0.05)。
- 整合上述预测因子的列线图表现出良好的区分度(AUC=0.84)、校准和临床效用。
局限性
- 随访完成率在30天为82.5%(99/120)、90天为76.7%(92/120)、≥180天为60.0%(72/120)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To validate ultrasound-derived fat fraction (UDFF) against histology for diagnosing hepatic steatosis, monitor metabolic changes after metabolic and bariatric surgery, and develop a pre-operative nomogram for predicting early steatosis normalization.
METHODS: A prospective cohort of 160 patients scheduled for metabolic and bariatric surgery was enrolled. Among them, 120 patients with biopsy-confirmed metabolic dysfunction-associated steatotic liver disease (hepatic fat ≥5%) underwent repeated assessments of UDFF, anthropometrics, and biochemical markers pre-operatively and at 30, 90, and ≥180 days post-operatively. Follow-up completion rates were 82.5%(99/120) at 30 days, 76.7% (92/120) at 90 days, and 60.0%(72/120) at ≥180 days. Using data from 92 patients with complete 90-day follow-up, a nomogram was developed via uni-variable and multi-variable logistic regression. Its performance was evaluated by the area under the curve (AUC), calibration, and decision curve analysis.
RESULTS: UDFF demonstrated a strong correlation with histological steatosis grade (Spearman's ρ=0.78;p<0.001) and high diagnostic accuracy for ≥S1 steatosis (AUC=0.99). Post-operative monitoring revealed rapid, phased reductions in UDFF, body weight, and triglyceride levels. Baseline weight, UDFF, and triglycerides were identified as independent predictors of steatosis normalization (all p<0.05). The nomogram integrating these predictors exhibited good discrimination (AUC=0.84), calibration, and clinical utility.
CONCLUSION: UDFF is a valid, non-invasive tool for quantifying hepatic steatosis and monitoring treatment response. The developed nomogram provides a practical means for the pre-operative identification of patients at risk for delayed normalization, thereby facilitating personalized surgical management and optimizing follow-up strategies.
引用
- Hu D, Yang H, Yu G, et al. Ultrasound-derived Fat Fraction for Pre-operative Prediction and Monitoring of Hepatic Steatosis Normalization After Metabolic Surgery in Patients With Obesity. Ultrasound Med Biol. 2026. PMID: 41765725. doi:10.1016/j.ultrasmedbio.2026.02.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。